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ABSTRACT 40 
Chlorogenic acid, a major polyphenol in edible plants, possesses strong antioxidant activity, 41 
anti-lipid peroxidation and anticancer effects. It used for industrial applications; however, this 42 
is limited by its instability to heat or light. In this study, we, for the first time synthesized 43 
chlorogenic acid glucoside (CHG) via transglycosylation using dextransucrase from 44 
Leuconostoc mesenteroides and sucrose. CHG was purified and its structure determined by 45 
nuclear magnetic resonance and matrix-associated laser desorption ionization–time-of-flight 46 
mass spectroscopy. The production yield of CHG was 44.0% or 141 mM, as determined by 47 
response surface methodology. CHG possessed a 65% increase in water solubility and a 2-48 
fold browning resistance and it displayed stronger inhibition of lipid peroxidation and of 49 
colon cancer cell growth by MTT assay, compared to chlorogenic acid. Therefore, this study 50 
may expand the industrial applications of chlorogenic acid as water-soluble or browning 51 
resistant compound (CHG) through enzymatic glycosylation. 52 
 53 
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1. Introduction 57 
Chlorogenic acid is one of the most abundant polyphenol in the human diet, and is 58 
consumed in coffee, fruits, and vegetables [1]. Chlorogenic acid is an ester -formed between 59 
quinic acid and certain trans-hydroxycinnamic acids, such as like caffeic, ferulic, or p-60 
coumaric acids [2–3]. It has three different isomers: 3-O-caffeoylquinic acid (chlorogenic 61 
acid), 5-O-caffeoylquinic acid (neo-chlorogenic acid) and 4-O-caffeoylquinic acid (krypto-62 
chlorogenic acid) [4–5]. Chlorogenic acid has antioxidant [2, 6], antimicrobial [7], and 63 
anxiolytic activity [8]. Recent reports indicate that this compound also exerts anti-64 
proliferative effects against some types of cancer cell, such as those from liver, blood, or 65 
brain cancer [9–11]. 66 
Due to the various beneficial effects of chlorogenic acid, it has been continually 67 
demanded as a functional compound in the food and pharmaceutical areas [12]. Even though 68 
there are many usages of chlorogenic acid, it is readily oxidized and sensitive to heat and 69 
light, which restricts its application in industry [13]. There have been attempts to improve the 70 
bioactivity or stability of light and heat sensitive compounds using enzymatic modification, 71 
such as glucansucrase, for extending their industrial applications [14–18]. Dextransucrase 72 
produces dextran using sucrose and also transfers glucose units to other carbohydrates, or 73 
phenolic acceptors via glycosidic linkages [17]. In our previous studies, enzymatic 74 
transglycosylation using dextransucrase was applied to modify various bioactive compounds 75 
in order to improve their physical or functional properties such as acarbose to be used as anti-76 
diabetic agents, salicin to increase blood coagulation, or hydroquinone to inhibit melanin 77 
synthesis [14, 15, 16]. Another bioactive compound, the glycosylated epigallocatechin gallate 78 
(EGCG) or glycosylated quercetin by dextransucrases were reported to be stable to UV 79 
radiation and were 100- or 12-fold more water soluble than the unstable EGCG or quercetin 80 
[17–18].  81 
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To our knowledge, there is no report of transglucosylation of chlorogenic acid using 82 
dextransucrase. In this study, chlorogenic acid-4-O-α-D-glucopyranoside (CHG) was 83 
synthesized using dextransucrase and sucrose. CHG was further purified by butanol 84 
extraction, silica gel column and preparative high-performance liquid chromatography 85 
(HPLC), and identified by nuclear magnetic resonance (NMR) and matrix-assisted laser 86 
desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). CHG production 87 
was optimized using the response surface methodology. The purified CHG was characterized 88 
for physical stability as well as its antioxidant activity, inhibition of lipid peroxidation, and 89 
viability of HT-29 colon cancer cells. 90 
 91 
2. Materials and methods 92 
2.1. Materials 93 
Chlorogenic acid, deuterium oxide, 1,1-diphenyl-2-picrylhydrazyl (DPPH), α-tocopherol 94 
and 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) were 95 
purchased from Sigma-Aldrich (St. Louis, MO, USA). Fetal bovine serum, penicillin, 96 
streptomycin, and Dulbecco’s modified Eagle’s medium (DMEM) were purchased from 97 
GIBCO BRL (Grand Island, NY, USA). Silica gel beads (40–60 µm) were purchased from 98 
Acros Organics (Geel, Belgium). Other chemical reagents were commercially available and 99 
of chemically pure grade. 100 
2.2. Production and purification of chlorogenic acid glucoside 101 
A dextransucrase mutant of L. mesenteroides B-1299 constitutive for dextransucrase 102 
(B-­‐512FMCM) was isolated after ethyl methane sulfonate mutagenesis and was cultured on 103 
LM medium using 2% (w/v) glucose [18]. The activity of partially purified enzyme was 104 
determined by incubation for 6 h at 28°C with 100 mM sucrose in 20 mM sodium acetate, pH 105 
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5.2 [18–19]. One unit of dextransucrase activity was defined as the amount of enzyme 106 
required to generate 1 µmol of fructose per minute at 28°C and pH 5.2 in 20 mM sodium 107 
acetate buffer [15]. 108 
The reaction mixture (1 L) in 20 mM Na-acetate (pH 5.2) consisting of 325 mM 109 
chlorogenic acid, 355 mM sucrose, and BF512 dextransucrase (650 mU/ml) was incubated at 110 
28°C for 6 h, and boiled for 10 min to stop the reaction. Chlorogenic acid glucoside was 111 
confirmed by thin layer chromatography (TLC) analysis (Merck, Darmstadt, Germany) at 112 
room temperature according to previous study with some modifications [16]. The reaction 113 
digest (1 L) was partitioned with the same volume of n-butanol to obtain chlorogenic acid 114 
modified products from the n-butanol layer. These were further concentrated and applied to a 115 
4.0 × 75 cm silica gel column and purified CHG was eluted with 85% (v/v) acetonitrile in 116 
water. The column was washed with distilled water to remove the remaining sugars 117 
(polymers, sucrose, and glucose). CHG purity was confirmed by HPLC under the following 118 
conditions: column TSK-GEL, amide-80, 5 µm (Waters, Milford, MA, USA); mobile phase, 119 
acetonitrile: water = 80:20 (v/v); flow rate, 1.0 mL/ min; room temperature; detection, RID-120 
10A RI detector (Shimadzu, Tokyo, Japan). 121 
2.3. Structural identification 122 
Purified CHG was assayed for its melting point (Stuart SMP10, Bibbly sterlin LTD, OSA, 123 
UK) and optical activity with [α]
25
D -10.3° + 0.11 c =1 in H2O (Jasco P-2000 Polarimeter, 124 
Ishikawa-Cho, TOKYO, Japan). You do not report the melting point in the results section.  125 
Purified CHG (5 mg/ml) was diluted with deionized water and then mixed 1:1 (v/v) with 2,5-126 
dihydroxybenzoic acid (1 mg/mL) dissolved in water. The mixed solution (1 µL) was then 127 
spotted onto a stainless steel plate and slowly dried at room temperature. The mass spectrum 128 
was acquired using a Voyager DE-STR MALDI-TOF (Voyager DE-STR, Applied 129 
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Biosystems, Poster, CA, USA). The mass spectra were obtained in the positive linear mode 130 
with delayed extraction (average of 75 laser shots) with a 65 kV acceleration voltage. 131 
Approximately 10 mg of purified CHG were dissolved in DMSO-d6 (250 µL) and placed into 132 
5 mm NMR tubes. NMR spectra were obtained on Avance-500 (Bruker, Pleasanton, CA, 133 
USA) from the National Center for Inter-University Research Facilities (Seoul National 134 
University, Seoul) operating at 500 MHz for 1H and 125 MHz for 13C at 25°C. The glucosidic 135 
linkage between chlorogenic acid and glucoside was determined via homo nuclear correlation 136 
spectroscopy (COSY), hetero nuclear single quantum coherence (HSQC), and hetero nuclear 137 
multiple bond correlation (HMBC) analyses [17]. 138 
2.4. Experimental design for optimized CHG production  139 
The experimental response surface methodology (RSM) data were fitted via the response 140 
surface regression procedure using the following second-order polynomial equation [20]: Y = 141 
β0 + β1X1 + β2X2 + β3X3+ β11X12 + β22X22 + β33X32+ β12X1X2 +β13X1X3+ β23X2X3.  The 142 
Design-Expert 6.0.11 central composite design RSM software (State-Ease, Minneapolis, MN, 143 
USA) was also used for regression analysis and graphical analysis of the data obtained during 144 
whole experiments. Analysis of variance was used to estimate the statistical parameters. The 145 
significance of the model equation and model terms was evaluated by Fisher’s test. The 146 
quality of fit for the polynomial model equation was expressed by the coefficient of 147 
determination (R2) and adjusted R2. The fitted polynomial equation was expressed as three-148 
dimensional surface plots to show the relationship between the responses and the 149 
experimental levels of each variables used in the design. The combination of optimized 150 
parameters producing the maximum response was determined to verify the validity of the 151 
model.  152 
2.5. Water solubility and browning resistance   153 
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Excess chlorogenic acid or CHG was mixed with 200 µl of water in an Eppendorf tube at 154 
room temperature. An ultrasonic cleaner was used to maximize solubility. After 1 h of 155 
sonication at room temperature, each sample was diluted and then filtered through a 0.45 µm 156 
MFS membrane for HPLC analyses to determine the maximum concentrations dissolved in 157 
water [17]. Browning resistance of each chlorogenic acid or CHG after UV irradiation in an 158 
aqueous system was evaluated in water (1 mL) containing 1 mM chlorogenic acid or CHG. 159 
The sample solutions were exposed to UV irradiation at a distance of 10 cm from the 254 nm, 160 
10 W UV source for 24 h at room temperature. Increases in absorbance at 460 nm were 161 
determined using a UV spectrophotometer [17].  162 
2.6. Functional characterization  163 
Chlorogenic acid and CHG were functionally studied with respect to their antioxidant, 164 
anti-lipid peroxidation, and HT29 cell growth inhibitory activities. The antioxidant activities 165 
of chlorogenic acid and CHG were assessed using DPPH radical scavenging assays [21]. IC50 166 
designated the concentration of the sample in which the levels of DPPH radicals were 167 
reduced by 50%. 168 
   Anti-lipid peroxidation activity was measured using a HP-CLA chemiluminescence-169 
measuring device (Tohoku Electronic Industrial, Tokyo, Japan) and an ARAL kit (ABCD 170 
GmbH, Berlin, Germany). According to the thermo-initiated chemiluminescence (TIC) 171 
method, the antioxidant species in the sample was incubated with ample free radical-attached 172 
luminol to delay generation of photons until the antioxidant species were consumed. The lag 173 
time (s) was proportional to the amount of antioxidant species in each sample [22]. 174 
HT29 human colon cancer cells, from a colonic adenocarcinoma of a female Caucasian, 175 
were purchased from the American Tissue Culture Collection (HTB-38™, Rockville, MD, 176 
USA). The cells were maintained in Dulbecco’s modified Eagle’s medium (Life 177 
Technologies, Inc., Grand Island, NY, USA) supplemented with 10% (v/v) heat-inactivated 178 
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fetal bovine serum, 100 U/mL penicillin, and 0.1 mg/mL streptomycin in a humidified 179 
atmosphere of 95% air and 5% CO2 at 37°C. Inhibition of cell growth was assessed by MTT 180 
assay. Percent cell viability was calculated as follows: cell viability (%) = (absorbance of the 181 
sample tested/absorbance of the medium only) × 100. The concentration of chlorogenic acid 182 
or CHG compound at which 50% of the cells survived (IC50) was also determined.  183 
 184 
3.  Results  185 
3.1. Synthesis and purification  186 
After the acceptor reaction of L. mesenteroides 512 FMCM dextransucrase with 187 
chlorogenic acid and sucrose, one reaction product, chlorogenic acid glucoside (CHG) was 188 
detected via TLC analysis (Fig. 1A). Butanol partitioning was used for the removal of 189 
unreacted or hydrolyzed carbohydrates and enzymes and the butanol layer was subjected to 190 
silica gel column chromatography and preparative HPLC purification (Fig. 1B). Chlorogenic 191 
acid and CHG in upper butanol layer were eluted by silica gel column chromatography using 192 
85% (v/v) acetonitrile in water. Pure CHG with 89% purity was obtained as a single band by 193 
HPLC analysis. The yield of CHG purification was 19.2 g (38.4% of total CHG synthesized). 194 
The purified CHG was obtained as a brownish-white powder. The final optimum conditions 195 
for CHG synthesis were 320 mM chlorogenic acid, 365 mM sucrose, and 0.96 U or 963 196 
mU/mL dextransucrase, which resulted in a yield of 141 mM (44.0% - v/v conversion of 197 
chlorogenic acid used). You can give the results of the melting point and optical activity here 198 
(see methods 2.3) 199 
3.2. Structural determination  200 
 The number of glucose units attached to compounds was verified using MALDI-TOF 201 
MS. The molecular weight of compounds was increased by attaching one glucose. The NMR 202 
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data of CHG (1H, 13C, COSY, HSQC, and HMBC) of chlorogenic acid and chlorogenic acid 203 
glucoside are shown in Table 1 and Fig. S1. The molecular ions of CHG were observed at 204 
m/z at 541 (M + Na)+. In Table 1, a doublet signal at 5.32 ppm (J=3.5 Hz) was assigned to 205 
the anomeric proton, showing that one glucosyl residue was α-linked to the chlorogenic acid 206 
(Fig. 2 and Table 1). 207 
Most carbon signals of CHG were significant with chlorogenic acid (Table 1), with 208 
chlorogenic acid exception of at 70.62 ppm to C-4, 68.40 ppm to C-5, 128.85 ppm to C-1', 209 
116.84 ppm to C-5', and 116.43 ppm to C-8'. From the HMBC data, a correlation was 210 
observed between the proton signal H-1'' of glucopyranoside and the C-4' of chlorogenic acid. 211 
The C-1'' of the glucosyl residue was detected at 99.54 ppm from the HSQC data. According 212 
to these results, the structure of CHG was confirmed as chlorogenic acid-4'-O-α-D-213 
glucopyranoside (Fig. 2). 214 
3.3 Optimum CHG Synthesis  215 
The effect of three variables (sucrose concentration, dextransucrase unit, and chlorogenic 216 
acid concentration) on the yield of CHG was determined. A total of 20 experiments were 217 
performed to investigate the interaction of these variables to CHG synthesis (Table S1 and 218 
S2). The response surface and their contour plots were described by the second-order 219 
polynomial equation (Fig. 3 and Table 2). As ascertained from the central points of the 220 
corresponding contour plots, the optimal conditions of the three variables were 365 mM 221 
sucrose, 963 mU/ml dextransucrase activity, and 320 mM chlorogenic acid. Values of “Prob 222 
> F” <0.05 indicate that model terms, x2, x3, x21, x22, x23, x1x2, and x1x3 are significant (Table 223 
S2). The response, CHG synthesis by dextransucrase acceptor reaction, was expressed in 224 
terms of the following regression equation: y = −178.7+0.29x1+0.29x2+0.74x3−0.000001x12− 225 
0.00002x22+0.000005x32− 0.00037x1x2−0.00014x1x3 −0.0011x2x3, where x1 is the sucrose 226 
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concentration (mM), x2 is the dextransucrase units (mU/ml), and x3 is the chlorogenic acid 227 
concentration (mM).  228 
The regression equation obtained from ANOVA indicated a R2 (multiple correlation 229 
coefficient) = 0.89, explaining 89% of the variation in response (Table S2). The “adequate 230 
precision value” of the present model was 7.78, suggesting that value above 4 are desirable 231 
for a good fitted model. Predicted response for CHG synthesis was 123.7 mM, and the 232 
observed experimental value was 124.8 + 9.62 mM at 355 mM sucrose, 650 mU/mL 233 
dextransucrase, and 325 mM chlorogenic acid, suggesting near identical results between the 234 
predicted and actual CHG synthesis. The results indicated only 0.9% difference between 235 
experimental and predicted CG synthesis. 236 
3.4.  Solubility and stability of CHG  237 
The water solubility of chlorogenic acid or CHG was tested using a method described 238 
previously [17, 23]. Chlorogenic acid and chlorogenic acid glucoside could be dissolved in 239 
water up to a concentration of 65.5 mM and 107.5 mM, respectively. The water solubility of 240 
chlorogenic acid was improved by 163% via glycosylation, indicating that attached glucosyl 241 
residues played a role in water solubility. These results agreed with those of our previous 242 
studies that reported higher solubility of EGCG or quercetin after glycosylation as compared 243 
to that of non-glycosylated compounds [17, 18]. 244 
Data on the browning resistance of chlorogenic acid or CHG in water is presented in (Fig. 245 
4A. Irradiation-associated browning of the chlorogenic acid glucoside conferred stability 246 
against UV irradiation (48% of that of chlorogenic acid). Both chlorogenic acid and CHG 247 
were labile to UV exposure at 60-120 min incubation period with high absorbance value as 248 
presented in Fig. 4A. 249 
 250 
3.5. Antioxidant or anti-lipid peroxidation activity  251 
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Progressive discoloration of DPPH in the presence of chlorogenic acid or CHG indicated 252 
that they were acting as antioxidant compounds. Chlorogenic acid and CHG, displayed 253 
different antioxidant activities depending on their structural configurations (Fig. 4B). The 254 
IC50 value of CHG based on its DPPH radical-scavenging activity was 0.39 mM, which was 255 
lower than that of chlorogenic acid (IC50 = 0.27 mM). As shown in Fig. 3B, the rate of 256 
scavenging activity increased with the increase of both concentrations. In addition, under the 257 
same chlorogenic acid concentration, CHG scavenged the DPPH radical more slowly did 258 
than cholorgenic acid.  259 
Chlorogenic acid exhibited varying anti-lipid peroxidation effects, depending on the 260 
structural configuration. Chlorogenic acid and CHG exhibited different magnitudes of 261 
inhibition of lipid peroxidation (Fig. 4C). Use of α-tocopherol or Vit E (10-100 µM) as a 262 
positive control, resulted in a dose dependent increase in chemiluminescent absorbance units 263 
(y = 0.9671x+2.8027, R² = 0.9889). At 500 µM, CHG showed 34% higher inhibition activity 264 
(27.2 U or 25.1 µM Vit E eq.) than chlorogenic acid (20.2 U or 17.9 µM Vit E eq.).  265 
 3.6. Inhibition of colon cancer cell growth  266 
We evaluated inhibition of HT29 cell growth by chlorogenic acid and CHG (0.01–5 mM) 267 
after 48 h of incubation by the MTT assay (Fig. 4D). CHG exhibited 18.4% greater inhibition 268 
of cell growth (IC50 1.58 mM) than chlorogenic acid (IC50 1.87 mM) (Fig. 4D). Up to 0.25 269 
mM, survival of HT29 cells by chlorogenic acid or CHG was not significantly affected. 270 
Treatment with 1.0 mM CHG or chlorogenic acid resulted in significantly decreased growth 271 
rate of HT29 cells by 46% or 52% survival rate of the control, respectively (Fig. 4D).  272 
 273 
4.  Discussion 274 
So far, chlorogenic acid and its isomers in plant source have been increased using cost-275 
effective process, physical or mechanical treatments. Chlorogenic acid and its isomers in 276 
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potatoes were 2-fold increased by treatment of exogenous amylolytic enzyme on wounded 277 
tuber surface [24–25]. Chlorogenic acid isomers in coffee bean were 1.9-fold increased by 278 
light brewing but 0.5–3 fold decreased by dark brewing [26]. Chlorogenic acid isomers are 279 
present in food materials and plants but information or reports about enzymatic 280 
transglucosylation is not available [5, 24-28]. 281 
CHG is synthesized via the acceptor reaction of dextransucrase with chlorogenic acid and 282 
sucrose. Chlorogenic acid was a suitable acceptor for the transglucosylation of dextransucrase 283 
with a high conversion yield (44.0%).  284 
The water solubility and browning resistance of chlorogenic acid were improved after 285 
glycosylation. This result is consistent with other previous report that glycoylated caffeic acid 286 
showed 2–65-fold increase in solubility as compared to caffeic acid itself, depending on the 287 
binding position of glucose [28]. The water solubility of caffeoyl 4-O-glucoside was about 288 
35-fold higher than that of caffeoyl 3-O-glucoside [28]. Glycosylated chlorogenic acid was 289 
48% more stable to UV radiation as compared to the unglycosylated compound itself in this 290 
study (Fig. 4A). Similarly, glycosylated caffeic acid did not changed color even after 291 
incubation for 4 d, while caffeic acid changed to a brown color after incubation for 1 d at 292 
50°C [28]. Glycoylated EGCG or ampelosin by dextransucrase also exhibited a 17% or 14.5-293 
fold improved browning-resistant quality than unglycosylated compounds [17, 23]. 294 
Interestingly, differing from water solubility, browning-resistant quality of compounds is 295 
conferred by glycosylation of the compounds, rather than the glycosylation positions and 296 
linkages of the resultant compounds [17, 23, 28].  . 297 
Our data indicated that attachment of a glucose to chlorogenic acid decreased its 298 
antioxidant activity but increased its anti-lipid perioxidation effect (Fig. 4B and 4C). 299 
Esterification of caffeic acid by a sugar moiety or quinic acid decreased its DPPH radical-300 
scavenging activity [29–30]. Glycosylated hydroquinone decreased its antioxidant activity 301 
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10-fold in vitro compared to that of hydroquinone [16]. Attachment of fructose and galactose 302 
to hydroquinone also resulted in six- to eight-fold decrease in antioxidant activity when 303 
compared to aglycon structures. However, a study reported that antioxidant activity can be 304 
determined by glucosidic linkage type (α or β) rather than attachment of sugar [20]. Most of 305 
the α-glucosidic linked hydroquinones displayed higher antioxidant activities than β-306 
glucosidic linked hydroquinones, irrespective of the sugar group attached [16, 20, 29]. 307 
However, glycosylated caffeic acid exhibited five-fold greater prevention of lipid 308 
autoxidation of linoleic acid compared to caffeic acid [28]. Moreover, the hydroquinone 309 
fructoside exerted slightly greater inhibition of lipid peroxidation than hydroquinone [16]. 310 
Chlorogenic acid significantly reduces the proliferation of human colon and lung cancer 311 
cells in a concentration- and time-dependent manner [31]. The survival of HT29 cells treated 312 
with chlorogenic acid and CHG did not differ significantly after 24 h. However, chlorogenic 313 
acid and CHG significantly inhibited survival of HT29 cells following incubation for 48 h. 314 
The rate of inhibition of cell growth was ~50% at >1 mM chlorogenic acid and significant 315 
loss of viability was evident after 48 h of treatment [31]. 316 
 317 
In summary, we report here the synthesis of chlorogenic acid glucoside via 318 
transglycosylation using dextransucrase from L. mesenteroides and sucrose. CHG was 319 
purified and identified by NMR and MALDI-TOF MS. The production yield of CHG was 320 
determined using the response surface methodology. CHG showed improved physical 321 
stability, and greater inhibition of lipid peroxidation and growth of colon cancer cell, 322 
compared to chlorogenic acid. Thus, CHG could be applicable as a novel functional 323 
compound in the food and pharmaceutical industries. 324 
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Table and Figure captions  433 
 434 
Fig. 1. Analysis of the transglucosylation product by TLC (A) and HPLC (B). 435 
(A) Lane 1: sucrose; lane 2: fructose; lane 3: glucose; lane 4: enzyme; lane 5: standard 436 
chlorogenic acid; lane 6: dextransucrase reaction digest. (B) HPLC chromatogram of 437 
chlorogenic acid glucoside after butanol separation and silica gel column chromatography. 438 
Column, TSK-GEL, amide-80, 5 µm (Waters, Milford, MA, USA); mobile phase, 439 
acetonitrile/water = 80:20 (v/v); flow rate, 1.0 ml/ min; room temperature; detection, RID-440 
10A RI detector (Shimadzu). 441 
 442 
Fig. 2. HMBC correlation of CHG between chlorogenic acid and glucosyl group 443 
 444 
Table 1.  445 
NMR analysis of chlorogenic acid and its glucoside, CHG 446 
 447 
Table 2. 448 
Central composite design matrix for the experimental design and predicted responses for 449 
CHG synthesisa  450 
 451 
Fig. 3. Response surface and contour plots of CHG production. Shown are the mutual 452 
interactions between dextransucrase and sucrose (A), chlorogenic acid and sucrose (B), and 453 
chlorogenic acid and dextransucrase (C). Synthesis of CHG was optimized by dextransucrase 454 
from L. mesenteroides (61–1238 mU/ml), sucrose concentration (10–700 mM), and 455 
chlorogenic acid concentration (30–619 mM). 456 
 457 
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Fig. 4. Browning resistance or functional study of chlorogenic acid and CHG with respect to 458 
DPPH scavenging activity, lipid peroxidation inhibition, and growth inhibition of HT-29 459 
human colon cancer cells. (A) After UV irradiation on at a distance of 10 cm from 254 nm, 460 
10 W for 6 h at room temperature, browning resistance of chlorogenic acid or CHG (1 mM) 461 
were determined by the increases in absorbance at 460 nm. (B) Each sample (30 µL), 462 
chlorgenic acid or CHG (0–2.0 mM), was mixed with 100 µM 1,1-diphenyl-2-picrylhydrazyl 463 
(270 µL) in darkness at room temperature for 10 min, and then the absorbance at 517nm was 464 
monitored. (C) Lipid peroxidation inhibition was measured using kits from ABCD GmbH 465 
and an HP-CLA chemiluminescence detection instrument (Tohoku, Japan). α-Tocopherol 466 
(10, 25, 50, and 100 µM) was used as a control and chlorogenic acid or CHG at 500 µM was 467 
used to determine inhibition of lipid peroxidation. Different letters above the bar are 468 
statistically different by Ducan's multiple range test (P < 0.05). (D) HT-29 cells (2 × 104 per 469 
well) were treated with a series of chlorogenic acid or CHG concentrations (0–20 mM) for 48 470 
h. Data are means ± SD of six independent experiments. * P <0.05 indicate significant 471 
difference from non- treated control.472 
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Table 1.   484 
NMR analysis of chlorogenic acid and its glucoside. 485 
 486 
Carbon position 
 Chlorogenic acid (δ)  Chlorogenic acid glucoside (δ1) 
 δC δH  δ1C (δ1-δ) δH 
Chlorogenic acid     
1  73.50      
2  36.45 5.07 (1H m)  36.56 (0.11) 1.93, 2.02 (2H, m) 
3   5.11 (1H, m)  71.14  5.09 
4  68.40 3.63 (1H, m)  70.62 (2.22) 3.56 
5  70.44 3.94 (1H, m)  68.40 (-2.04) 3.92 
6  37.18 5.07 (1H, m)  37.27 (0.09) 1.77, 2.07 (2H, m) 
7  174.85   175.15  (0.3)  
1'  125.60   128.85  (3.25)  
2'  115.74 7.04 (1H, d, J=1.17Hz)  115.00  (-0.73) 7.15 (1H, d, J=2 Hz) 
3'  145.53 9.15 (1H, s)  147.32  (1.79) 8.91 (1H, s) 
4'  148.30 9.57 (1H, s)  147.12  (-1.17)  
5'  114.73 6.77 (1H, d, J=8.20 Hz)  116.84  (2.11) 7.21 (1H, d, J=8.5 Hz) 
6'  121.31 6.99 (1H dd J=1.17 8.20 Hz)  120.76  (-0.55) 7.09 (1H, dd, J=2, 8.5 Hz) 
7'  144.89 7.43 (1H, d, J=16.11 Hz)  144.31  (-0.58) 7.47 (1H, d, J=16 Hz) 
8'  114.31 6.16 (1H, d, J=16.11 Hz)  116.43  (2.12) 6.32 (1H, d, J=16 Hz) 
9'  165.71   165.61  (-0.1)  
Glucose        
1''     99.53   5.32 (1H, d, J=3.5 Hz) 
2''     71.97  3.34 (1H, m) 
3''     73.08  3.69 (1H, m) 
4''     69.90  3.18 (1H, m) 
5''     73.87  3.45 (1H, m) 
6''     60.67  3.49, 3.60 (2H, m) 
25 
 
Table 2. 487 
Central composite design matrix for the experimental design and predicted responses for 488 
CHG synthesisa  489 
Run no. 
Coded levels CHG synthesis (mM) 
X1 X2 X3 Actual Predicted 
1 150 300 150 35.2 16.7 
2 560 300 150 29.4 24.9 
3 150 1000 150 111.2 87.5 
4 560 1000 150 108.7 95.2 
5 150 300 500 26.0 14.2 
6 560 300 500 20.7 19.1 
7 150 1000 500 107.2 86.4 
8 560 1000 500 97.6 90.8 
9 10.2 650 325 41.3 73.6 
10 699.8 650 325 80.8 84.3 
11 355 61.4 325 3.3 12.7 
12 355 1238.6 325 106.2 132.5 
13 355 650 30.7 2.7 26.3 
14 355 650 619.3 8.4 20.5 
15 355 650 325 126.4 123.7 
16 355 650 325 112.8 123.7 
17 355 650 325 125.4 123.7 
18 355 650 325 138.6 123.7 
19 355 650 325 115.1 123.7 
20 355 650 325 130.3 123.7 
a y = −178.7+0.29x1+0.29x2+0.74x3−0.000001x12−0.00002x22 +0.000005x32− 0.00037x1x2 490 
−0.00014x1x3−0.0011x2x3 491 
 492 
 493 
 494 
 495 
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